BE645036A - - Google Patents
Info
- Publication number
- BE645036A BE645036A BE645036A BE645036A BE645036A BE 645036 A BE645036 A BE 645036A BE 645036 A BE645036 A BE 645036A BE 645036 A BE645036 A BE 645036A BE 645036 A BE645036 A BE 645036A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR857672A FR1301267A (fr) | 1961-04-04 | 1961-04-04 | Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation |
| FR866961 | 1961-07-04 | ||
| GB1238163A GB1015026A (en) | 1961-04-04 | 1963-03-28 | New derivatives of 2-oxazolidinone and the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE645036A true BE645036A (US06818201-20041116-C00086.png) | 1964-09-11 |
Family
ID=27245932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE645036A BE645036A (US06818201-20041116-C00086.png) | 1961-04-04 | 1964-03-11 |
Country Status (2)
| Country | Link |
|---|---|
| BE (1) | BE645036A (US06818201-20041116-C00086.png) |
| GB (1) | GB1015026A (US06818201-20041116-C00086.png) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10210195B4 (de) * | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
-
1963
- 1963-03-28 GB GB1238163A patent/GB1015026A/en not_active Expired
-
1964
- 1964-03-11 BE BE645036A patent/BE645036A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1015026A (en) | 1965-12-31 |
